Tri Locum Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Tri Locum Partners’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-120,687	Closed	-$4.78M	–	37
2024 Q1	$4.78M	Buy	+120,687	New	+$3.56M	1.66%	22
2023 Q4	–	Sell	-314,029	Closed	-$3.6M	–	65
2023 Q3	$3.6M	Sell	314,029 -17,963	-5%	-$221K	1.15%	28
2023 Q2	$3.41M	Buy	+331,992	New	+$2.99M	1.27%	23

Tri Locum Partners's ALPN Position: Q2 2024 in Review

Tri Locum Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 120,687 shares — an estimated $4.78M sold.

Tri Locum Partners first reported a position in ALPN in Q2 2023 and held it in 3 quarters. The position peaked at $4.78M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Tri Locum Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Tri Locum Partners sold 120,687 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.78M.
Tri Locum Partners first reported a position in Alpine Immune Sciences Inc in Q2 2023 and held it in 3 quarters.
Tri Locum Partners's Alpine Immune Sciences Inc position peaked at $4.78M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Tri Locum Partners's 13F filing for Q2 2024, filed 14 Aug 2024.